semaglutide getting banned GLP-1 weight-loss drugs are a hot health topic. Now, critics are debating whether the medications should be in sports for potentially being performance-enhancing drugs. https://fox5sandiego.com/news/critics-concerned-glp-1-drugs-may-give Compounded GLP-1 ban: What providers

Journal of Postgraduate Medicine

This review covers everything: pricing math, what real patients report, the regulatory landscape for compounded GLP-1 medications, and how Mochi stacks up against Hims, Ro, and other telehealth weight loss platforms

Weight-loss drug Wegovy produces largest benefit ever seen for patients with most common form of heart failure, trial finds Audio By Vocalize The diabetes and weight loss drug semaglutide significantly reduced symptoms and improved quality of life in people with obesity and the most common form of heart failure in a clinical trial, potentially expanding the already wildly popular drugs use beyond diabetes and weight loss and offering a new treatment option where few are available

A pharmacokinetic study involved just five healthy males and focused on absorption rates rather than GLP-1 effects

Proactive Strategies Dealing with retatrutide-related fatigue translates into actionable strategies for everyday life